NasdaqGM - Nasdaq Real Time Price
USD
Scribe Therapeutics Inc. (SCTX)
14.70
-0.72
(-4.67%)
As of 9:50:12 AM EST. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| AGHAZADEH BEHZAD PH.D. Director and Beneficial Owner of more than 10% of a Class of Security |
Purchase | Jul 28, 2026 | -- |
| AH BIO FUND II LP Beneficial Owner of more than 10% of a Class of Security |
Purchase | Jul 27, 2026 | -- |
| DOUDNA JENNIFER A. PH.D. Beneficial Owner of more than 10% of a Class of Security |
Conversion of Exercise of derivative security | Jul 27, 2026 | 603,547 |
| GORDON CARL L Director |
Purchase | Jul 27, 2026 | -- |
| LUCAS SVETLANA Officer |
Purchase | Jul 23, 2026 | -- |
| ORBIMED ADVISORS, L.L.C. Director |
Purchase | Jul 27, 2026 | -- |
| PARROT DAVID L. Chief Financial Officer |
Purchase | Jul 23, 2026 | -- |
